• OPEN AN ACCOUNT
Indian Indices
Sensex
74,459.53 308.49
( 0.42%)
Global Indices
Nasdaq
51,732.40 -631.16
(-1.21%)
Dow Jones
7,581.68 -159.71
(-2.06%)
Hang Seng
63,176.05 -1,483.42
(-2.29%)
Nikkei 225
10,722.51 0.44
(0.00%)
Forex
USD-INR
95.22 0.06
(0.06%)
EUR-INR
106.19 0.24
(0.23%)
GBP-INR
127.01 0.44
(0.35%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Asston Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
544445
INE0SJX01015
60.9571459
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
42.1
164.63
EPS(TTM)
Face Value()
Div & Yield %
3.58
10
0
 

Shree Renuka Sugars reports consolidated net loss of Rs 122.20 crore in the March 2026 quarter
May 09,2026
Net loss of Shree Renuka Sugars reported to Rs 122.20 crore in the quarter ended March 2026 as against net profit of Rs 91.60 crore during the previous quarter ended March 2025. Sales declined 6.12% to Rs 2546.90 crore in the quarter ended March 2026 as against Rs 2713.00 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 792.10 crore in the year ended March 2026 as against net loss of Rs 299.80 crore during the previous year ended March 2025. Sales declined 13.49% to Rs 9160.50 crore in the year ended March 2026 as against Rs 10589.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2546.902713.00 -6 9160.5010589.10 -13
OPM %1.5210.76 -0.215.68 -
PBDT-80.30161.20 PL -580.50-83.00 -599
PBT-153.2090.90 PL -872.30-362.60 -141
NP-122.2091.60 PL -792.10-299.80 -164